|
India
on African Safari
While Europe and US still figure on the priority list of the
Indian pharmaceutical companies, there is Africa which is
not high in the list. But it is not a market small enough
to be ignored either. Nandini Patwardhan finds out what Indian
pharma is up to in Africa.
India
and China in Goa
Adding to the hot weather of Goa, were even more heated debates
on China, India, IPR and CRAMS at the Frost & Sullivan's
summit on 'Opportunities in Lifesciences Molecules'. Arshiya
Khan reports
A
Gateway to China
AchemAsia 2007 greeted its attendees with music and fanfare
at the opening ceremony of the Seventh International Exhibition-Congress
on Chemical Engineering and Biotechnology. The event was held
at the China International Exhibition Centre in Beijing.
Wyeth
introduces Tygacil in India
Wyeth has introduced Tygacil (tigecycline) in select cities
in India following its approval by the Drug Controller General
of India.
Intas
in R&D pact with Virionics
Intas Biopharmaceuticals Limited (IBPL) has entered into a
strategic R&D agreement with US-based Virionics for development
of Human Papilloma Virus (HPV-16 and HPV-18) therapeutic vaccine.
Shasun
acquires Rhodia's UK operations
Shasun made a maiden acquisition of Rhodia's custom synthesis
and contract manufacturing business in UK through Shasun Pharma
Solutions.
Zydus
launches anti-obesity drug
Zydus Cadila has launched an anti-obesity drug Slimona in
India. Slimona (Rimonabant) is a selective CB1 Endocannabinoid
(EC) receptor antagonist indicated for the treatment of obesity.
Strides
opens sterile facility in Brazil
Cellofarm announced the inauguration of its sterile injectable
facility for penems and penicillins at Compos in Rio de Janeiro,
Brazil. Built at a cost of $30 million, this facility will
become a global site for the Strides group's growing sterile
business.
'The
brands are from high value segments'
Ranbaxy's recent acquisition of 13 brands from Bristol Myers
Squibb(BMS) is considered a good strategic move by many. What
is it that initiated this significant deal? Sushmi Dey finds
out in conversation with Ramesh Adige, Executive Director,
Ranbaxy.
Elder
in collaboration with Cymbiotics
Elder Pharmaceuticals has entered into a product licensing
collaboration with Cymbiotics.
Glenmark's
molecule enters Phase II
Glenmark Pharmaceuticals SA, the Swiss subsidiary of Glenmark
Pharmaceuticals, has completed Phase I clinical trials for
GRC 6211 in Europe.
Vedic
Lifesciences partners with US based CRO
Vedic Lifesciences signed an agreement with Amarex, a clinical
research organisation headquartered at Germantown, MD, USA
to collaborate on clinical development and regulatory affairs
services for botanical drugs in the US and India.
'Online
clinics provide hardcore visibility'
Homeopathy is alternative medicine and those who embraced
it, like Dr Batras' Positive Health Clinics are choosing alternative
ways to reach out. Dr Mukesh Batra, Chairman and Managing
Director talks to Arshiya Khan about their online clinics
and the homeopathy market.
Global
biotech makes historic advances
Ernst & Young's 21st anniversary report on the biotechnology
industry tells us why biotech is called the science of the
future.
|
